| Reference |
|---|
Jung K, Ku J, Kwon J, Won G, Yoon H, Oh S, et al. IFN-γ/TNF-α Synergism Induces Pro-Inflammatory Cytokine and Chemokine Production by In Vitro Canine Keratinocytes. Vet Sci. 2025;12: pubmed publisher |
Costa S, Soares M, Poleto Bragato J, Dos Santos M, Rebech G, de Freitas J, et al. MicroRNA-194 regulates parasitic load and IL-1β-dependent nitric oxide production in the peripheral blood mononuclear cells of dogs with leishmaniasis. PLoS Negl Trop Dis. 2024;18:e0011789 pubmed publisher |
Pelst M, H xf6 bart C, de Rooster H, Devriendt B, Cox E. Immortalised canine buccal epithelial cells' CXCL8 secretion is affected by allergen extracts, Toll-like receptor ligands, IL-17A and calcitriol. Vet Res. 2022;53:72 pubmed publisher |
Bragato J, Rebech G, Freitas J, Santos M, Costa S, Eug xea nio F, et al. miRNA-21 regulates CD69 and IL-10 expression in canine leishmaniasis. PLoS ONE. 2022;17:e0265192 pubmed publisher |
Abbott J, Chan S, MacBeth M, Crooks J, Hancock C, Knight V, et al. Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles. PLoS ONE. 2022;17:e0265852 pubmed publisher |
Verde M, Villanueva Saz S, Loste A, Marteles D, Pereboom D, Conde T, et al. Comparison of circulating CD4+, CD8+ lymphocytes and cytokine profiles between dogs with atopic dermatitis and healthy dogs. Res Vet Sci. 2022;145:13-20 pubmed publisher |
Alcolea P, Alonso A, Esteban A, Peris P, Cortés A, Castillo J, et al. IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis. PLoS ONE. 2019;14:e0212136 pubmed publisher |
Oliveira Silva K, Marin Chiku V, Luvizotto Venturin G, Correa Leal A, de Almeida B, de Rezende Eugênio F, et al. PD-1 and PD-L1 regulate cellular immunity in canine visceral leishmaniasis. Comp Immunol Microbiol Infect Dis. 2019;62:76-87 pubmed publisher |
Wheat W, Chow L, Kurihara J, Regan D, Coy J, WEBB T, et al. Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical Pathways. Stem Cells Dev. 2017;26:249-262 pubmed publisher |
Resende L, Aguiar Soares R, Gama Ker H, Roatt B, Mendonça L, Alves M, et al. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge. PLoS ONE. 2016;11:e0161169 pubmed publisher |
MacDiarmid J, Langova V, Bailey D, Pattison S, Pattison S, Christensen N, et al. Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model. PLoS ONE. 2016;11:e0151832 pubmed publisher |
Shahbazi M, Zahedifard F, Taheri T, Taslimi Y, Jamshidi S, Shirian S, et al. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis. PLoS ONE. 2015;10:e0132794 pubmed publisher |
Costa Pereira C, Moreira M, Soares R, Marteleto B, Ribeiro V, França Dias M, et al. One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis. BMC Vet Res. 2015;11:92 pubmed publisher |
Figueiredo M, Deoti B, Amorim I, Pinto A, Moraes A, Carvalho C, et al. Expression of regulatory T cells in jejunum, colon, and cervical and mesenteric lymph nodes of dogs naturally infected with Leishmania infantum. Infect Immun. 2014;82:3704-12 pubmed publisher |
Aparicio Burgos J, Ochoa García L, Zepeda Escobar J, Gupta S, Dhiman M, Martínez J, et al. Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs. PLoS Negl Trop Dis. 2011;5:e1050 pubmed publisher |
Fernandes A, Costa M, Coelho E, Michalick M, de Freitas E, Melo M, et al. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine. 2008;26:5888-95 pubmed publisher |
